CBIH (Cannabis Bioscience International Holdings) ROA %: -3,466.67% (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cannabis Bioscience International Holdings ROA %?

Cannabis Bioscience International Holdings CBIH +33.33% ROA % is -3,466.67% as of Feb. 2026. The stock has 4 warning signs investors should review. Among 1,009 Drug Manufacturers companies, Cannabis Bioscience International Holdings ranks worse than 99.9% on this metric.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Cannabis Bioscience International Holdings's annualized Net Income for the quarter that ended in Feb. 2026 was $-0.42 Mil. Cannabis Bioscience International Holdings's average Total Assets over the quarter that ended in Feb. 2026 was $0.01 Mil. Therefore, Cannabis Bioscience International Holdings's annualized ROA % for the quarter that ended in Feb. 2026 was -3,466.67%.

The historical rank and industry rank for Cannabis Bioscience International Holdings's ROA % or its related term are showing as below:

CBIH' s ROA % Range Over the Past 10 Years
Min: -2866.67   Med: -48.82   Max: 59.98
Current: -2866.67

During the past 8 years, Cannabis Bioscience International Holdings's highest ROA % was 59.98%. The lowest was -2866.67%. And the median was -48.82%.

CBIH's ROA % is ranked worse than
99.9% of 1009 companies
in the Drug Manufacturers industry
Industry Median: 2.72 vs CBIH: -2866.67

Cannabis Bioscience International Holdings  (OTCPK:CBIH) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Feb. 2026 )
=Net Income/Total Assets
=-0.416/0.012
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.416 / 0.044)*(0.044 / 0.012)
=Net Margin %*Asset Turnover
=-945.45 %*3.6667
=-3,466.67 %

Note: The Net Income data used here is four times the quarterly (Feb. 2026) net income data. The Revenue data used here is four times the quarterly (Feb. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Cannabis Bioscience International Holdings ROA % Related Terms


Cannabis Bioscience International Holdings ROA % Historical Data

* Premium members only.

The historical data trend for Cannabis Bioscience International Holdings's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Bioscience International Holdings ROA % Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11 May23 May24 May25
ROA %
Get a 7-Day Free Trial -25.22 12.69 -2.22 -1,302.00 -1,233.71

Cannabis Bioscience International Holdings Quarterly Data
Nov10 Feb11 May11 Aug11 Nov11 Feb12 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,896.00 -3,608.51 -1,301.96 -2,282.93 -3,466.67

CBIH vs SXTC, UPC, NPHC: ROA % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings ROA % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's ROA % distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's ROA % falls into.



Cannabis Bioscience International Holdings ROA % Calculation

Cannabis Bioscience International Holdings's annualized ROA % for the fiscal year that ended in May. 2025 is calculated as:

ROA %=Net Income (A: May. 2025 )/( (Total Assets (A: May. 2024 )+Total Assets (A: May. 2025 ))/ count )
=-0.549/( (0.057+0.032)/ 2 )
=-0.549/0.0445
=-1,233.71 %

Cannabis Bioscience International Holdings's annualized ROA % for the quarter that ended in Feb. 2026 is calculated as:

ROA %=Net Income (Q: Feb. 2026 )/( (Total Assets (Q: Nov. 2025 )+Total Assets (Q: Feb. 2026 ))/ count )
=-0.416/( (0.022+0.002)/ 2 )
=-0.416/0.012
=-3,466.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Feb. 2026) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of -3,466.67% mean?
Cannabis Bioscience International Holdings (CBIH) has a ROA % of -3,466.67% as of Feb. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Cannabis Bioscience International Holdings and its competitors. According to the industry distribution chart, Cannabis Bioscience International Holdings ranks #1008 out of 1009 companies in the Drug Manufacturers industry, placing it in the top 99.9%.
Is Cannabis Bioscience International Holdings' ROA % too high?
Cannabis Bioscience International Holdings' current ROA % is -3,466.67%. Based on the distribution chart, Cannabis Bioscience International Holdings ranks #1008 out of 1009 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Cannabis Bioscience International Holdings' ROA % compare to SXTC and UPC?
According to the Drug Manufacturers industry distribution chart, Cannabis Bioscience International Holdings ranks #1008 out of 1009 companies for ROA %. This places Cannabis Bioscience International Holdings in the lower half of its industry. The industry median ROA % is 2.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Drug Manufacturers company?
The median ROA % among Drug Manufacturers companies is 2.72, based on 1,009 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Cannabis Bioscience International Holdings and its competitors. For the Drug Manufacturers industry, the median ROA % is 2.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Bioscience International Holdings's current ROA % is -3,466.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Bioscience International Holdings stock overvalued right now?
Cannabis Bioscience International Holdings (CBIH) has a current ROA % of -3,466.67%. The current ROA % is -3,466.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Cannabis Bioscience International Holdings (CBIH), the current ROA % is -3,466.67% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Bioscience International Holdings Business Description

Address 6201 Bonhomme Road, Suite 435N, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc operates in three main areas. Firstly, the company engages in cannabis-related research and education under the trade name Pharmacology University. Secondly, it serves as both a Sponsor and a Contract Research Organization (CRO) in clinical trials, some of which involve cannabis and CBD products, under the trade name Alpha Research Institute. Lastly, the company plans to manufacture, market, and sell CBD products branded as "VitaCookies." The majority of the company's revenue comes from clinical trial contracts, while a smaller portion is generated from cannabis-related educational classes and seminars.